1. Jemal, A, Center, MM, DeSantis, C, et al. Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Biomarkers Prev 2010; 19: 1893–1907.
Google Scholar | Crossref | Medline | ISI2. Yothers, G, O’Connell, MJ, Lee, M, et al. Validation of the 12-gene colon cancer recurrence score in NSABP C-07 as a predictor of recurrence in patients with stage II and III colon cancer treated with fluorouracil and leucovorin (FU/LV) and FU/LV plus oxaliplatin. J Clin Oncol 2013; 31: 4512–4519.
Google Scholar | Crossref | Medline3. Klaver, CEL, Wisselink, DD, Punt, CJA, et al. Adjuvant hyperthermic intraperitoneal chemotherapy in patients with locally advanced colon cancer (COLOPEC): a multicentre, open-label, randomised trial. Lancet Gastroenterol Hepatol 2019; 4: 761–770.
Google Scholar | Crossref | Medline4. Van Cutsem, E, Nordlinger, B, Cervantes, A. Advanced colorectal cancer: ESMO clinical practice guidelines for treatment. Ann Oncol 2010; 21: v93–v97.
Google Scholar | Crossref | Medline | ISI5. Kanas, GP, Taylor, A, Primrose, JN, et al. Survival after liver resection in metastatic colorectal cancer: review and meta-analysis of prognostic factors. Clin Epidemiol 2012; 4: 283–301.
Google Scholar | Medline6. Mayo, SC, Pawlik, TM. Current management of colorectal hepatic metastasis. Expert Rev Gastroenterol Hepatol 2009; 3: 131–144.
Google Scholar | Crossref | Medline7. Bugge, TH, Antalis, TM, Wu, Q. Type II transmembrane serine proteases. J Biol Chem 2009; 284: 23177–23181.
Google Scholar | Crossref | Medline8. de Aberasturi, AL, Calvo, A. TMPRSS4: an emerging potential therapeutic target in cancer. Br J Cancer 2015; 112: 4–8.
Google Scholar | Crossref | Medline9. Jung, H, Lee, KP, Park, SJ, et al. TMPRSS4 Promotes invasion, migration and metastasis of human tumor cells by facilitating an epithelial-mesenchymal transition. Oncogene 2008; 27: 2635–2647.
Google Scholar | Crossref | Medline10. Kim, S, Kang, HY, Nam, EH, et al. TMPRSS4 Induces invasion and epithelial-mesenchymal transition through upregulation of integrin alpha5 and its signaling pathways. Carcinogenesis 2010; 31: 597–606.
Google Scholar | Crossref | Medline11. Min, HJ, Lee, Y, Zhao, XF, et al. TMPRSS4 Upregulates uPA gene expression through JNK signaling activation to induce cancer cell invasion. Cell Signal 2014; 26: 398–408.
Google Scholar | Crossref | Medline12. Zeng, P, Zhang, P, Zhou, LN, et al. TMPRSS4 As an emerging potential poor prognostic factor for solid tumors: a systematic review and meta-analysis. Oncotarget 2016; 7: 76327–76336.
Google Scholar | Crossref | Medline13. Huang, A, Zhou, H, Zhao, H, et al. High expression level of TMPRSS4 predicts adverse outcomes of colorectal cancer patients. Med Oncol 2013; 30: 712.
Google Scholar | Crossref | Medline14. Amin, MB, Greene, FL, Edge, SB, et al. The eighth edition AJCC cancer staging manual: continuing to build a bridge from a population-based to a more “personalized” approach to cancer staging. CA Cancer J Clin 2017; 67: 93–99.
Google Scholar | Crossref | Medline | ISI15. Bhargava, R, Chen, B, Klimstra, DS, et al. Comparison of two antibodies for immunohistochemical evaluation of epidermal growth factor receptor expression in colorectal carcinomas, adenomas, and normal mucosa. Cancer 2006; 106: 1857–1862.
Google Scholar | Crossref | Medline16. Kimura, M, Tsuda, H, Morita, D, et al. A proposal for diagnostically meaningful criteria to classify increased epidermal growth factor receptor and c-erbB-2 gene copy numbers in gastric carcinoma, based on correlation of fluorescence in situ hybridization and immunohistochemical measurements. Virchows Arch 2004; 445: 255–262.
Google Scholar | Crossref | Medline17. Lim, CS, Alexander-Sefre, F, Allam, M, et al. Clinical value of immunohistochemically detected lymphovascular space invasion in early stage cervical carcinoma. Ann Surg Oncol 2008; 15: 2581–2588.
Google Scholar | Crossref | Medline18. Park, KJ, Choi, HJ, Roh, MS, et al. Intensity of tumor budding and its prognostic implications in invasive colon carcinoma. Dis Colon Rectum 2005; 48: 1597–1602.
Google Scholar | Crossref | Medline19. Puppa, G, Sonzogni, A, Colombari, R, et al. TNM Staging system of colorectal carcinoma: a critical appraisal of challenging issues. Arch Pathol Lab Med 2010; 134: 837–852.
Google Scholar | Crossref | Medline20. Liang, B, Wu, M, Bu, Y, et al. Prognostic value of TMPRSS4 expression in patients with breast cancer. Med Oncol 2013; 30: 497.
Google Scholar | Crossref | Medline21. Larzabal, L, Nguewa, PA, Pio, R, et al. Overexpression of TMPRSS4 in non-small cell lung cancer is associated with poor prognosis in patients with squamous histology. Br J Cancer 2011; 105: 1608–1614.
Google Scholar | Crossref | Medline22. Kebebew, E, Peng, M, Reiff, E, et al. Diagnostic and extent of disease multigene assay for malignant thyroid neoplasms. Cancer 2006; 106: 2592–2597.
Google Scholar | Crossref | Medline23. Huang, A, Zhou, H, Zhao, H, et al. TMPRSS4 correlates with colorectal cancer pathological stage and regulates cell proliferation and self-renewal ability. Cancer Biol Ther 2014; 15: 297–304.
Google Scholar | Crossref | Medline24. Jiang, WG, Puntis, MC, Hallett, MB. Molecular and cellular basis of cancer invasion and metastasis: implications for treatment. Br J Surg 1994; 81: 1576–1590.
Google Scholar | Crossref | Medline | ISI25. Nakamura, T, Mitomi, H, Kikuchi, S, et al. Evaluation of the usefulness of tumor budding on the prediction of metastasis to the lung and liver after curative excision of colorectal cancer. Hepatogastroenterology 2005; 52: 1432–1435.
Google Scholar | Medline26. Settakorn, J, Khunamornpong, S, Sukpan, K, et al. Cyclooxygenase-2 expression in cervical squamous cell carcinoma: the significance of expression in neoplastic cells within the lymphovascular space. Asian Pac J Cancer Prev 2009; 10: 1011–1014.
Google Scholar | Medline27. Cheng, Y, Wang, K, Geng, L, et al. Identification of candidate diagnostic and prognostic biomarkers for pancreatic carcinoma. EBioMedicine 2019; 40: 382–393.
Google Scholar | Crossref | Medline28. Villalba, M, Diaz-Lagares, A, Redrado, M, et al. Epigenetic alterations leading to TMPRSS4 promoter hypomethylation and protein overexpression predict poor prognosis in squamous lung cancer patients. Oncotarget 2016; 7: 22752–22769.
Google Scholar | Crossref | Medline29. Wang, CH, Guo, ZY, Chen, ZT, et al. TMPRSS4 Facilitates epithelial-mesenchymal transition of hepatocellular carcinoma and is a predictive marker for poor prognosis of patients after curative resection. Sci Rep 2015; 5: 12366.
Google Scholar | Crossref | Medline